Protease inhibitors

Details for Australian Patent Application No. 2004312547 (hide)

Owner Taigen Biotechnology

Inventors Chen, Wen-Chang; Su, Feng-Yih; Yang, Syaulan; Wang, Ching-Cheng; Kuo, Chun-Wei; Wu, Jen-Dar; Xiang, Yibin; Liao, Shao-Ying

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004312547

PCT Pub. Number WO2005/066123

Priority 60/533,779 31.12.03 US

Filing date 28 December 2004

Wipo publication date 21 July 2005

International Classifications

C07D 207/04 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/06 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 223/02 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/066123 Priority application(s): WO2005/066123

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004312548-Targeted immunogens

2004312546-Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases